Release Date: 28/02/19 16:27 Summary: Appendix 4E - Preliminary Report Price Sensitive: Yes Download Document 627.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%